Involvement of purinergic signaling in cellular response to γ radiation

Radiation Research

Volumn 173, Issue 3, 2010, Pages 298-309

  Tsukimoto, Mitsutoshi ^a,b   Homma, Takujiro ^a   Ohshima, Yasuhiro ^a   Kojima, Shuji ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b Strategic Promotion Program for Basic Nuclear Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APYRASE; CALCIUM ION; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PURINERGIC P2 RECEPTOR; SURAMIN; URIDINE TRIPHOSPHATE;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; GAMMA RADIATION; HUMAN; HUMAN CELL; IONIZING RADIATION; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 77749246293     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1732.1     Document Type: Article

References (50)

1. M. F. Lavin, S. Kozlov, N. Gueven, C. Peng, G. Birrell, P. Chen and S. Scott, Atm and cellular response to DNA damage. Adv. Exp. Med. Biol. 570, 457-476 (2005).
2. N. Hamada, H. Matsumoto, T. Hara and Y. Kobayashi, Intercellular and intracellular signaling pathways mediating ionizing radiation-induced bystander effects. J. Radiat. Res. (Tokyo) 48, 87-95 (2007).
3. H. Zhou, G. Randers-Pehrson, C. A. Waldren, D. Vannais, E. J. Hall and T. K. Hei, Induction of a bystander mutagenic effect of alpha particles in mammalian cells. Proc. Natl. Acad. Sci. USA 97, 2099-2104 (2000).
4. C. Mothersill and C. Seymour, Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells. Int. J. Radiat. Biol. 71, 421-427 (1997).
5. E. I. Azzam, S. M. de Toledo and J. B. Little, Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc. Natl. Acad. Sci. USA 98, 473-478 (2001).
6. H. Yang, N. Asaad and K. D. Held, Medium-mediated intercellular communication is involved in bystander responses of X-ray-irradiated normal human fibroblasts. Oncogene 24, 2096-2103 (2005).
7. E. I. Azzam, S. M. De Toledo, D. R. Spitz and J. B. Little, Oxidative metabolism modulates signal transduction and micronucleus formation in bystander cells from alpha-particle-irradiated normal human fibroblast cultures. Cancer Res. 62, 5436-5442 (2002).
8. N. Balaban, J. Moni, M. Shannon, L. Dang, E. Murphy and T. Goldkorn, The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim. Biophys. Acta 1314, 147-156 (1996).
9. R. K. Schmidt-Ullrich, R. B. Mikkelsen, P. Dent, D. G. Todd, K. Valerie, B. D. Kavanagh, J. N. Contessa, W. K. Rorrer and P. B. Chen, Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 15, 1191-1197 (1997).
10. B. M. Paddle and G. Burnstock, Release of ATP from perfused heart during coronary vasodilatation. Blood Vessels 11, 110-119 (1974).
11. M. M. Borst and J. Schrader, Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ. Res. 68, 797-806 (1991).
12. H. Darius, G. L. Stahl and A. M. Lefer, Pharmacologic modulation of ATP release from isolated rat hearts in response to vasoconstrictor stimuli using a continuous flow technique. J. Pharmacol. Exp. Ther. 240, 542-547 (1987).
13. E. H. Abraham, A. G. Prat, L. Gerweck, T. Seneveratne, R. J. Arceci, R. Kramer, G. Guidotti and H. F. Cantiello, The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc. Natl. Acad. Sci. USA 90, 312-316 (1993).
14. M. L. Cotrina, J. H. Lin, A. Alves-Rodrigues, S. Liu, J. Li, H. Azmi-Ghadimi, J. Kang, C. C. Naus and M. Nedergaard, Connexins regulate calcium signaling by controlling ATP release. Proc. Natl. Acad. Sci. USA 95, 15735-15740 (1998). (Pubitemid 29018769)
15. S. Locovei, L. Bao and G. Dahl, Pannexin 1 in erythrocytes: function without a gap. Proc. Natl. Acad. Sci. USA 103, 7655-7659 (2006).
16. P. D. Bell, J. Y. Lapointe, R. Sabirov, S. Hayashi, J. Peti-Peterdi, K. Manabe, G. Kovacs and Y. Okada, Macula densa cell signaling involves ATP release through a maxi anion channel. Proc. Natl. Acad. Sci. USA 100, 4322-4327 (2003).
17. G. Burnstock, Introduction: P2 receptors. Curr. Top. Med. Chem. 4, 793-803 (2004).
18. B. S. Khakh and R. A. North, P2X receptors as cell-surface ATP sensors in health and disease. Nature 442, 527-532 (2006).
19. H. Yoshida, D. Kobayashi, S. Ohkubo and N. Nakahata, ATP stimulates interleukin-6 production via P2Y receptors in human HaCaT keratinocytes. Eur. J. Pharmacol. 540, 1-9 (2006).
20. W. K. Lee, S. W. Choi, H. R. Lee, E. J. Lee, K. H. Lee and H. O. Kim, Purinoceptor-mediated calcium mobilization and proliferation in HaCaT keratinocytes. J. Dermatol. Sci. 25, 97-105 (2001).
21. 2z waves in keratinocytes are transmitted to sensory neurons: the involvement of extracellular ATP and P2Y2 receptor activation. Biochem. J. 380, 329-338 (2004).
22. K. Inoue, J. Hosoi and M. Denda, Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J. Invest. Dermatol. 127, 362-371 (2007).
23. S. Ahmad, A. Ahmad and C. W. White, Purinergic signaling and kinase activation for survival in pulmonary oxidative stress and disease. Free Radic. Biol. Med. 41, 29-40 (2006).
24. R. A. North, Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067 (2002).
25. I. von Kugelgen and A. Wetter, Molecular pharmacology of P2Y-receptors. Naunyn. Schmiedebergs Arch. Pharmacol. 362, 310-323 (2000).
26. F. Di Virgilio, P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi and O. R. Baricordi, Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97, 587-600 (2001).
27. B. S. Khakh, G. Burnstock, C. Kennedy, B. F. King, R. A. North, P. Seguela, M. Voigt and P. P. Humphrey, International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev. 53, 107-118 (2001).
28. G. Lambrecht, K. Braun, M. Damer, M. Ganso, C. Hildebrandt, H. Ullmann, M. U. Kassack and P. Nickel, Structure-activity relationships of suramin and pyridoxal-59-phosphate derivatives as P2 receptor antagonists. Curr. Pharm. Des. 8, 2371-2399 (2002).
29. L. K. Mamedova, B. V. Joshi, Z. G. Gao, I. von Kugelgen and K. A. Jacobson, Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochem. Pharmacol. 67, 1763-1770 (2004).
30. G. Hollopeter, H. M. Jantzen, D. Vincent, G. Li, L. England, V. Ramakrishnan, R. B. Yang, P. Nurden, A. Nurden, D. Julius and P. B. Conley, Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409, 202-207 (2001). (Pubitemid 32144286)
31. Y. C. Kim, J. S. Lee, K. Sak, F. Marteau, L. Mamedova, J. M. Boeynaems and K. A. Jacobson, Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. Biochem. Pharmacol. 70, 266-274 (2005).
32. D. W. Nelson, R. J. Gregg, M. E. Kort, A. Perez-Medrano, E. A. Voight, Y. Wang, G. Grayson, M. T. Namovic, D. L. Donnelly-Roberts and W. A. Carroll, Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. J. Med. Chem. 49, 3659-3666 (2006).
33. W. H. Ward, P. N. Cook, A. M. Slater, D. H. Davies, G. A. Holdgate and L. R. Green, Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor. Biochem. Pharmacol. 48, 659-666 (1994).
34. J. H. Hanke, J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok and P. A. Connelly, Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependent T cell activation. J. Biol. Chem. 271, 695-701 (1996).
35. D. Riewe, L. Grosman, A. R. Fernie, C. Wucke and P. Geigenberger, The potato-specific apyrase is apoplastically localized and has influence on gene expression, growth, and development. Plant. Physiol. 147, 1092-1109 (2008).
36. P. A. Riley, Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int. J. Radiat. Biol. 65, 27-33 (1994).
37. J. G. Fitz, Regulation of cellular ATP release. Trans. Am. Clin. Climatol. Assoc. 118, 199-208 (2007).
38. H. Zimmermann and N. Braun, Ecto-nucleotidases\molecular structures, catalytic properties, and functional roles in the nervous system. Prog. Brain Res. 120, 371-385 (1999).
39. E. R. Lazarowski and R. C. Boucher, UTP as an extracellular signaling molecule. News Physiol. Sci. 16, 1-5 (2001).
40. K. D. Lustig, M. G. Sportiello, L. Erb and G. A. Weisman, A nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionized forms of ATP and UTP. Biochem. J. 284, 733-739 (1992).
41. F. M. Lyng, P. Maguire, B. McClean, C. Seymour and C. Mothersill, The involvement of calcium and MAP kinase signaling pathways in the production of radiation-induced bystander effects. Radiat. Res. 165, 400-409 (2006).
42. P. Bodin, D. Bailey and G. Burnstock, Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br. J. Pharmacol. 103, 1203-1205 (1991).
43. Z. Li, Y. Hosoi, K. Cai, Y. Tanno, Y. Matsumoto, A. Enomoto, A. Morita, K. Nakagawa and K. Miyagawa, Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation. Biochem. Biophys. Res. Commun. 341, 363-368 (2006).
44. D. Erlinge, Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen. Pharmacol. 31, 1-8 (1998). (Pubitemid 28239746)
45. J. Liu, Z. Liao, J. Camden, K. D. Griffin, R. C. Garrad, L. I. Santiago-Perez, F. A. Gonzalez, C. I. Seye, G. A. Weisman and L. Erb, Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J. Biol. Chem. 279, 8212-8218 (2004).
46. J. Andreev, M. L. Galisteo, O. Kranenburg, S. K. Logan, E. S. Chiu, M. Okigaki, L. A. Cary, W. H. Moolenaar and J. Schlessinger, Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J. Biol. Chem. 276, 20130-20135 (2001).
47. A. Pines, L. Perrone, N. Bivi, M. Romanello, G. Damante, M. Gulisano, M. R. Kelley, F. Quadrifoglio and G. Tell, Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic. Acids Res. 33, 4379-4394 (2005).
48. L. Erb, Z. Liao, C. I. Seye and G. A. Weisman, P2 receptors: intracellular signaling. Pflugers Arch. 452, 552-562 (2006).
49. Y. Hu, P. L. Fisette, L. C. Denlinger, A. G. Guadarrama, J. A. Sommer, R. A. Proctor and P. J. Bertics, Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J. Biol. Chem. 273, 27170-27175 (1998).
50. B. C. Suh, J. S. Kim, U. Namgung, H. Ha and K. T. Kim, P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J. Immunol. 166, 6754-6763 (2001).